MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Lung cancer remains a leading cause of cancer mortality globally.
• MicroRNAs (miRNAs) play crucial roles in cellular processes, including cancer development.
• Existing treatments for lung cancer have limitations, necessitating novel therapeutic approaches.

Purpose of the Study:

• To investigate the role of microRNA-9 to 1 (miR-9 to 1) in lung cancer.
• To identify the molecular targets of miR-9 to 1 involved in lung cancer suppression.
• To elucidate the mechanism by which miR-9 to 1 inhibits lung cancer progression.

Main Methods:

• Overexpression of miR-9 to 1 in lung cancer cell lines (A549).
• Assessment of cell proliferation, colony formation in vitro, and tumorigenicity in vivo.
• Identification of UHRF1 as a direct target of miR-9 to 1 using molecular assays.
• Analysis of cell cycle regulators (p15, p16, p21) at mRNA and protein levels.

Main Results:

• Overexpression of miR-9 to 1 significantly suppressed lung cancer cell proliferation, colony formation, and tumorigenicity.
• Ubiquitin-like containing PHD and RING finger domains 1 (UHRF1) was identified as a direct target of miR-9 to 1.
• miR-9 to 1-mediated inhibition of UHRF1 led to G1 cell cycle arrest.
• Re-expression of tumor suppressor genes p15, p16, and p21 was observed at both mRNA and protein levels in the miR-9 to 1 group.

Conclusions:

• miR-9 to 1 acts as a tumor suppressor in lung cancer by targeting UHRF1.
• The miR-9 to 1/UHRF1 axis regulates cell proliferation through the re-expression of p15, p16, and p21.
• UHRF1 represents a novel therapeutic target for miR-9 to 1-based lung cancer treatment.